Lavipharm S.A (LAVI) — Cash Flow-to-Debt Ratio
Lavipharm S.A (LAVI) has a Cash Flow-to-Debt Ratio of 0.01x as of December 2022, meaning its operating cash flow of €527.00K could theoretically repay 0% of its total liabilities (€73.89 Million) in one year. See LAVI free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Lavipharm S.A Cash Flow-to-Debt Ratio (2014–2024)
Historical debt coverage capacity for Lavipharm S.A across 11 annual periods. Also explore Lavipharm S.A (LAVI) net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Lavipharm S.A (2014–2024)
Year-by-year debt coverage analysis for Lavipharm S.A. For market capitalisation and broader financial context, see LAVI market cap overview.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.06x | €4.64 Million | €72.52 Million | ▲ +1522.5% |
| 2023 | 0.00x | €284.00K | €72.02 Million | ▼ -91.3% |
| 2022 | 0.05x | €3.35 Million | €73.89 Million | ▼ -25.7% |
| 2021 | 0.06x | €3.82 Million | €62.68 Million | ▲ +34.6% |
| 2020 | 0.05x | €2.85 Million | €62.94 Million | ▼ -0.1% |
| 2019 | 0.05x | €2.89 Million | €63.82 Million | ▲ +96.5% |
| 2018 | 0.02x | €1.42 Million | €61.43 Million | ▼ -1.4% |
| 2017 | 0.02x | €1.51 Million | €64.73 Million | ▲ +208.8% |
| 2016 | 0.01x | €606.00K | €80.00 Million | ▲ +93.1% |
| 2015 | 0.00x | €576.00K | €146.80 Million | ▼ -78.1% |
| 2014 | 0.02x | €2.38 Million | €132.79 Million | — |